Impact of lung infection on health and well-being
Part of Infections, Lungs & breathing clinical trials.
This study looks at how chronic pulmonary aspergillosis (a long-term lung infection) affects your daily life, health, and overall well-being. By joining, you'll help researchers understand what it's like to live with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with chronic pulmonary aspergillosis (CPA).
- You must be able to speak and understand English.
- You must be willing and able to give your permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of inhaled liposomal amphotericin B (Ambisome) plus itraconazole works better for chronic pulmonary aspergillosis (CPA). It may help control long-term Aspergillus lung infection and symptoms.
This study will use special scans to see how an inhaled antifungal medicine (amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis. The results may help doctors choose better treatments in the future.
This study looks closely at how influenza (the flu) and a specific kind of lung fungus called Aspergillus affect people who are sick in the ICU with breathing problems. It may help doctors better understand the cause and improve treatment for severe lung infections.
This study looks at samples from your lungs that contain Aspergillus fungus to understand why some fungi become resistant to antifungal medicines. By joining, you help researchers find better ways to treat these infections.
This study looks at how the presence of fungus in lung samples relates to the long-term outlook for people with allergic bronchopulmonary aspergillosis (ABPA). It aims to help doctors better understand the disease and guide treatment.
This study looks at Aspergillus infections in people admitted to the hematology ward. It aims to understand how common these infections are and how they affect patients.
Hear when a new Chronic Pulmonary Aspergillosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.